Yongze Li
-
- Thyroid Disorders and Treatments 31
- Thyroid Cancer Diagnosis and Treatment 21
- Growth Hormone and Insulin-like Growth Factors 8
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Nephrology top 10%
- Endocrine and Autonomic Systems top 10%
- Epidemiology top 10%
- HIV, Drug Use, Sexual Risk 5
- Obstetrics and Gynecology top 10%
-
- Vitamin D Research Studies 8
-
- HIV/AIDS Research and Interventions 6
-
- Air Quality and Health Impacts 5
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yongze Li
77 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Endocrinology, Diabetes and Metabolism 747
- Nephrology 73
- Endocrine and Autonomic Systems 66
- Epidemiology 325
- Obstetrics and Gynecology 73
Countries citing papers authored by Yongze Li
This map shows the geographic impact of Yongze Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongze Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongze Li more than expected).
Fields of papers citing papers by Yongze Li
This network shows the impact of papers produced by Yongze Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongze Li. The network helps show where Yongze Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yongze Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 20 | |
| 9 | 2023 | 11 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 65 | |
| 13 | 2021 | 9 | |
| 14 | 2021 | 46 | |
| 15 | 2020 | 10 | |
| 16 | 2019 | 83 | |
| 17 | 2019 | 32 | |
| 18 | 2018 | 5 | |
| 19 | 2016 | 1 | |
| 20 | 2016 | 3 |
About Yongze Li
Yongze Li is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Health, Toxicology and Mutagenesis, having authored 83 papers that have together received 1.8k indexed citations. Recurring topics across this work include Thyroid Disorders and Treatments (31 papers), Thyroid Cancer Diagnosis and Treatment (21 papers), Vitamin D Research Studies (8 papers), Growth Hormone and Insulin-like Growth Factors (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), HIV/AIDS Research and Interventions (6 papers), HIV, Drug Use, Sexual Risk (5 papers) and Air Quality and Health Impacts (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (747 citations), Nephrology (73 citations) and Endocrine and Autonomic Systems (66 citations). Yongze Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhongyan Shan, Weiping Teng, Shuangning Ding, Xu Han, Xiaoguang Shi, Bing Ma, Cheng Han, Yaxin Lai, Xinghai Xia and Jinxin Lü.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.